Motoneurons and CD4+ effector T cell subsets: Neuroprotection and repair

Clinical Neuroscience Research

Volumn 6, Issue 1-2, 2006, Pages 86-96

  Byram, Susanna C ^a   Serpe, Craig J ^b   DeBoy, Cynthia A ^a   Sanders, Virginia M ^c   Jones, Kathryn J ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

ALS; CD4+T cells; Facial nerve injury; FMN; Neuro immune interactions; Neuroprotection

Indexed keywords

CD4 ANTIGEN; CYTOKINE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CONVALESCENCE; DEGENERATIVE DISEASE; DISEASE MODEL; EFFECTOR CELL; FACIAL NERVE INJURY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MOTONEURON; MOTOR NEURON DISEASE; NERVE FIBER REGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 33746700731     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2006.06.001     Document Type: Article

References (100)

1. Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol 5 6 (2004) 575-581
2. Ide C. Peripheral nerve regeneration. Neurosci Res 25 2 (1996) 101-121
3. Profyris C., Cheema S.S., Zang D., Azari M.F., Boyle K., and Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 15 3 (2004) 415-436
4. Serpe C.J., Coers S., Sanders V.M., and Jones K.J. CD4+T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection. Brain Behav Immun 17 5 (2003) 393-402
5. McGeer P.L., and McGeer E.G. Inflammation and the degenerative diseases of aging. Ann NY Acad Sci 1035 (2004) 104-116
6. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 18 3 (2005) 315-321
7. Pannu R., Barbosa E., Singh A.K., and Singh I. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J Neurosci Res 79 3 (2005) 340-350
8. Verma P., Chierzi S., Codd A.M., et al. Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration. J Neurosci 25 2 (2005) 331-342
9. Bisby M.A., and Tetzlaff W. Changes in cytoskeletal protein synthesis following axon injury and during axon regeneration. Mol Neurobiol 6 2-3 (1992) 107-123
10. Serpe C.J., Kohm A.P., Huppenbauer C.B., Sanders V.M., and Jones K.J. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J Neurosci 19 11 (1999) RC7
11. Karni A., Balashov K., Hancock W.W., et al. Cyclophosphamide modulates CD4+T cells into a T helper type 2 phenotype and reverses increased IFN-γ production of CD8+T cells in secondary progressive multiple sclerosis. J Neuroimmunol 146 1-2 (2004) 189-198
12. Byram S.C., Serpe C.J., Pruett S.B., Sanders V.M., and Jones K.J. Natural killer cells do not mediate facial motoneuron survival after facial nerve transection. Brain Behav Immun 17 6 (2003) 417-425
13. Lieberman A.R. The axon reaction: a review of the principal features of perikaryal responses to axon injury. Int Rev Neurobiol 14 (1971) 49-124
14. Byram S.C., Carson M.J., DeBoy C.A., Serpe C.J., Sanders V.M., and Jones K.J. CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J Neurosci 24 18 (2004) 4333-4339
15. Murphy K.M., Heimberger A.B., and Loh D.Y. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250 4988 (1990) 1720-1723
16. Sedgwick J.D., and Hickey W.F. Antigen presentation in the central nervous system. In: Keane R.W., and Hickey W.F. (Eds). Immunology and the Nervous System (1997), Oxford University Press, New York 364
17. Hickey W.F., and Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239 4837 (1988) 290-292
18. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 7 (1986) 2348-2357
19. Spellberg B., and Edwards Jr. J.E. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 32 1 (2001) 76-102
20. Rao A., and Avni O. Molecular aspects of T-cell differentiation. Br Med Bull 56 4 (2000) 969-984
21. Gajewski T.F., and Fitch F.W. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 140 12 (1988) 4245-4252
22. Hsieh C.S., Heimberger A.B., Gold J.S., O'Garra A., and Murphy K.M. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci USA 89 13 (1992) 6065-6069
23. Kaplan M.H., Sun Y.L., Hoey T., and Grusby M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382 6587 (1996) 174-177
24. Wurster A.L., Tanaka T., and Grusby M.J. The biology of Stat4 and Stat6. Oncogene 19 21 (2000) 2577-2584
25. Kaplan M.H., Schindler U., Smiley S.T., and Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4 3 (1996) 313-319
26. Takeda K., Tanaka T., Shi W., et al. Essential role of Stat6 in IL-4 signalling. Nature 380 6575 (1996) 627-630
27. Harling-Berg C., Knopf P.M., Merriam J., and Cserr H.F. Role of cervical lymph nodes in the systemic humoral immune response to human serum albumin microinfused into rat cerebrospinal fluid. J Neuroimmunol 25 2-3 (1989) 185-193
28. Kida S., Pantazis A., and Weller R.O. CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathol Appl Neurobiol 19 6 (1993) 480-488
29. Zhang E.T., Richards H.K., Kida S., and Weller R.O. Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol (Berl) 83 3 (1992) 233-239
30. Hunter J.V., Batchelder K.F., Lo E.H., and Wolf G.L. Imaging techniques for in vivo quantitation of extracranial lymphatic drainage of the brain. Neuropathol Appl Neurobiol 21 3 (1995) 185-188
31. Knopf P.M., Cserr H.F., Nolan S.C., Wu T.Y., and Harling-Berg C.J. Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain. Neuropathol Appl Neurobiol 21 3 (1995) 175-180
32. Olsson T., Diener P., Ljungdahl A., Hojeberg B., van der Meide P.H., and Kristensson K. Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Autoimmunity 13 2 (1992) 117-126
33. Ling C., Sandor M., and Fabry Z. In situ processing and distribution of intracerebrally injected OVA in the CNS. J Neuroimmunol 141 1-2 (2003) 90-98
34. Swanson M.A., Lee W.T., and Sanders V.M. IFN-γ production by Th1 cells generated from naive CD4+T cells exposed to norepinephrine. J Immunol 166 1 (2001) 232-240
35. Ramer-Quinn D.S., Baker R.A., and Sanders V.M. Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol 159 10 (1997) 4857-4867
36. Goldsby R.A., Kindt T.J., and Osborne B.A. Introduction. Kuby Immunology. 4th ed (2000), Freeman Press, New York
37. Bajenoff M., Wurtz O., and Guerder S. Repeated antigen exposure is necessary for the differentiation, but not the initial proliferation, of naive CD4(+) T cells. J Immunol 168 4 (2002) 1723-1729
38. Lederer J.A., Perez V.L., DesRoches L., Kim S.M., Abbas A.K., and Lichtman A.H. Cytokine transcriptional events during helper T cell subset differentiation. J Exp Med 184 2 (1996) 397-406
39. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., and Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259 5102 (1993) 1739-1742
40. Metwali A., Elliott D., Blum A.M., et al. The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. J Immunol 157 10 (1996) 4546-4553
41. DeBoy CA, Xin, J., Byram SC, Serpe CJ, Sanders VM, Jones KJ. 2006. Immune-mediated neuroprotection of axotomized mouse facial motoneurons 3 is dependent on the IL-4/STAT6 signaling pathway in CD4+T cells. Exp. Neurol., In Press.
42. Graeber M.B., and Kreutzberg G.W. Delayed astrocyte reaction following facial nerve axotomy. J Neurocytol 17 2 (1988) 209-220
43. Graeber M.B., Streit W.J., and Kreutzberg G.W. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J Neurosci Res 21 1 (1988) 18-24
44. Streit W.J., Graeber M.B., and Kreutzberg G.W. Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol 21 2-3 (1989) 117-123
45. Laskawi R., and Wolff J.R. Changes in glial fibrillary acidic protein immunoreactivity in the rat facial nucleus following various types of nerve lesions. Eur Arch Otorhinolaryngol 253 8 (1996) 475-480
46. Streit W.J., Semple-Rowland S.L., Hurley S.D., Miller R.C., Popovich P.G., and Stokes B.T. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 152 1 (1998) 74-87
47. Carson M.J., and Sutcliffe J.G. Balancing function vs. self defense: the CNS as an active regulator of immune responses. J Neurosci Res 55 1 (1999) 1-8
48. Streit W.J., Walter S.A., and Pennell N.A. Reactive microgliosis. Prog Neurobiol 57 6 (1999) 563-581
49. Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40 2 (2002) 133-139
50. Carson M.J. Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia 40 2 (2002) 218-231
51. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., and Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149 8 (1992) 2736-2741
52. Raivich G., Liu Z.Q., Kloss C.U., Labow M., Bluethmann H., and Bohatschek M. Cytotoxic potential of proinflammatory cytokines: combined deletion of TNF receptors TNFR1 and TNFR2 prevents motoneuron cell death after facial axotomy in adult mouse. Exp Neurol 178 2 (2002) 186-193
53. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 6603 (1996) 787-793
54. Wirjatijasa F., Dehghani F., Blaheta R.A., Korf H.W., and Hailer N.P. Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells. J Neurosci Res 68 5 (2002) 579-587
55. Yang M.S., Park E.J., Sohn S., et al. Interleukin-13 and -4 induce death of activated microglia. Glia 38 4 (2002) 273-280
56. Kaal E.C., Joosten E.A., and Bar P.R. Prevention of apoptotic motoneuron death in vitro by neurotrophins and muscle extract. Neurochem Int 31 2 (1997) 193-201
57. Liem R.S., Brouwer N., and Copray J.C. Ultrastructural localisation of intramuscular expression of BDNF mRNA by silver-gold intensified non-radioactive in situ hybridisation. Histochem Cell Biol 116 6 (2001) 545-551
58. Yan Q., Elliott J., and Snider W.D. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 360 6406 (1992) 753-755
59. Yan Q., Elliott J.L., Matheson C., et al. Influences of neurotrophins on mammalian motoneurons in vivo. J Neurobiol 24 12 (1993) 1555-1577
60. Hughes R.A., Sendtner M., and Thoenen H. Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J Neurosci Res 36 6 (1993) 663-671
61. Novikov L., Novikova L., and Kellerth J.O. Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo. Neuroscience 79 3 (1997) 765-774
62. Sakamoto T., Kawazoe Y., Shen J.S., et al. Adenoviral gene transfer of GDNF, BDNF and TGF beta 2, but not CNTF, cardiotrophin-1 or IGF1, protects injured adult motoneurons after facial nerve avulsion. J Neurosci Res 72 1 (2003) 54-64
63. Wu W., Li L., Yick L.W., et al. alter the expression of neuronal NOS, c-Jun, and p75 and prevent motoneuron death following spinal root avulsion in adult rats. J Neurotrauma 20 6 (2003) 603-612
64. Besser M., and Wank R. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J Immunol 162 11 (1999) 6303-6306
65. Kerschensteiner M., Gallmeier E., Behrens L., et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J Exp Med 189 5 (1999) 865-870
66. Hammarberg H., Lidman O., Lundberg C., et al. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 20 14 (2000) 5283-5291
67. Muhallab S., Lundberg C., Gielen A.W., et al. Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis. Scand J Immunol 55 3 (2002) 264-273
68. Ziemssen T., Kumpfel T., Klinkert W.E., Neuhaus O., and Hohlfeld R. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 152 Pt 11 (2002) 2381-2391
69. Sekimoto M., Tsuji T., Matsuzaki J., et al. Functional expression of the TrkC gene, encoding a high affinity receptor for NT-3, in antigen-specific T helper type 2 (Th2) cells. Immunol Lett 88 3 (2003) 221-226
70. Serpe C.J., Byram S.C., Sanders V.M., and Jones K.J. Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice. Brain Behav Immun 19 2 (2005) 173-180
71. Raivich G., Jones L.L., Kloss C.U., Werner A., Neumann H., and Kreutzberg G.W. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci 18 15 (1998) 5804-5816
72. Olsson T., Kristensson K., Ljungdahl A., Maehlen J., Holmdahl R., and Klareskog L. Gamma-interferon-like immunoreactivity in axotomized rat motor neurons. J Neurosci 9 11 (1989) 3870-3875
73. Harrison J.K., Jiang Y., Chen S., et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 95 18 (1998) 10896-10901
74. Zujovic V., Benavides J., Vige X., Carter C., and Taupin V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29 4 (2000) 305-315
75. Umehara H., Bloom E.T., Okazaki T., Nagano Y., Yoshie O., and Imai T. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 24 1 (2004) 34-40
76. Zhou X., Rodriguez W.I., Casillas R.A., et al. Axotomy-induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus. J Neurosci Res 57 6 (1999) 953-961
77. Armstrong B.D., Hu Z., Abad C., et al. Lymphocyte regulation of neuropeptide gene expression after neuronal injury. J Neurosci Res 74 2 (2003) 240-247
78. Delgado M., Abad C., Martinez C., et al. PACAP in immunity and inflammation. Ann NY Acad Sci 992 (2003) 141-157
79. Somogyvari-Vigh A., and Reglodi D. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr Pharm Des 10 23 (2004) 2861-2889
80. Armstrong B.D., Abad C., Chhith S., et al. Restoration of axotomy-induced PACAP gene induction in SCID mice with CD4+T-lymphocytes. Neuroreport 15 17 (2004) 2647-2650
81. Kim W.K., Kan Y., Ganea D., Hart R.P., Gozes I., and Jonakait G.M. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway. J Neurosci 20 10 (2000) 3622-3630
82. Delgado M., Leceta J., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cells. Faseb J 16 13 (2002) 1844-1846
83. Ganea D., and Delgado M. Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP. Arch Immunol Ther Exp (Warsz) 49 2 (2001) 101-110
84. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25 12 (2004) 677-686
85. Fu S.Y., and Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 14 1-2 (1997) 67-116
86. Chen S., and Bisby M.A. Long-term consequences of impaired regeneration on facial motoneurons in the C57BL/Ola mouse. J Comp Neurol 335 4 (1993) 576-585
87. Aharoni R., Teitelbaum D., Sela M., and Arnon R. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 94 20 (1997) 10821-10826
88. Aharoni R., Kayhan B., Eilam R., Sela M., and Arnon R. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ. Proc Natl Acad Sci USA 100 24 (2003) 14157-14162
89. Angelov D.N., Waibel S., Guntinas-Lichius O., et al. Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 100 8 (2003) 4790-4795
90. Mulder D.W., Kurland L.T., Offord K.P., and Beard C.M. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36 4 (1986) 511-517
91. Alexianu M.E., Kozovska M., and Appel S.H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57 7 (2001) 1282-1289
92. Engelhardt J.I., Tajti J., and Appel S.H. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 50 1 (1993) 30-36
93. Lampson L.A., Kushner P.D., and Sobel R.A. Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann Neurol 28 3 (1990) 365-372
94. Troost D., van den Oord J.J., de Jong J.M., and Swaab D.F. Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol 8 6 (1989) 289-294
95. Graves M.C., Fiala M., Dinglasan L.A., et al. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord 5 4 (2004) 213-219
96. Chen L.C., Smith A., Ben Y., et al. Temporal gene expression patterns in G93A/SOD1 mouse. Amyotroph Lateral Scler Other Motor Neuron Disord 5 3 (2004) 164-171
97. Jiang Y.M., Yamamoto M., Kobayashi Y., et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 57 2 (2005) 236-251
98. Karlsson J., Fong K.S., Hansson M.J., Elmer E., Csiszar K., and Keep M.F. Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis. J Neurosurg 101 1 (2004) 128-137
99. Appel S.H., Smith R.G., Engelhardt J.I., and Stefani E. Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci 124 (1994) 14-19
100. Kong J., and Xu Z. Peripheral axotomy slows motoneuron degeneration in a transgenic mouse line expressing mutant SOD1 G93A. J Comp Neurol 412 2 (1999) 373-380